BALANCE SHEET COMPONENTS (Tables)

3 Months Ended

Mar. 31, 2026

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Inventory

Inventory comprised the following amounts:

	March 31, 2026		December 31, 2025
Finished goods	$	315	$	107
Work in process	1,324		994
Raw materials	1,852		1,886
Inventory	$	3,491	$	2,987

Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets comprised the following amounts:

	March 31, 2026		December 31, 2025
Prepayment for insurance	$	245	$	324
Advance payments for inventory purchases	292		300
Deferred Private Placement issuance costs	87		—

Other	527		448
Prepaid expenses and other current assets	$	1,151	$	1,072

Property, Plant and Equipment, Net

Useful lives are as follows.

Asset Class	Estimated Useful Life
Machinery & equipment	5 years
Computer equipment and office equipment	3 to 5 years
Purchased software	3 to 5 years
Leasehold improvements	Shorter of remaining lease term or useful life

Property and equipment comprised the following amounts:

	March 31, 2026		December 31, 2025
Machinery and equipment	$	993	$	928
Computer equipment, office equipment, and purchased software	101		101
Leasehold improvements	157		157
Accumulated depreciation and amortization	(631)		(575)
Property and equipment, net	$	620	$	611

Accrued Expense and Other Current Liabilities

Accrued expenses and other current liabilities comprised the following:

	March 31, 2026		December 31, 2025
Accrued compensation	$	502	$	568
Accrued clinical trial expenses	125		83
Accrued R&D expenses	2,085		1,448
Accrued sales taxes	40		79
Other	742		519
Accrued expenses and other current liabilities	$	3,494	$	2,697